Evidence map›Paper›PMID 33233455›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.

Karen Alejandra Méndez-Lara, Nicole Letelier, Núria Farré, Elena M G Diarte-Añazco, Núria Nieto-Nicolau, Elisabeth Rodríguez-Millán, David Santos, Victor Pallarès, Joan Carles Escolà-Gil, Tania Vázquez Del Olmo and 6 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. NADCell communication and signaling : CCS · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. NADJournal of lipid and atherosclerosis · 2022
    Review
  8. Effects of nicotinamide on follicular development and the quality of oocytes.Reproductive biology and endocrinology : RB&E · 2022
    Article
  9. Sirtuin 3 Dependent and Independent Effects of NADAntioxidants (Basel, Switzerland) · 2022
    Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Karen Alejandra Méndez-LaraInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau i Institut d'Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0002-8372-2310
Nicole LetelierDepartament de Biologia Cel·lular, Fisiologia i Immunologia. Facultat de Biologia, Universitat de Barcelona i Institut de Biomedicina de la Universitat de Barcelona (IBUB), 08028 Barcelona, Spain.
Núria FarréServei de Bioquímica, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08041 Barcelona, Spain.
Elena M G Diarte-AñazcoInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau i Institut d'Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.
Núria Nieto-NicolauInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau i Institut d'Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.
Elisabeth Rodríguez-MillánInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau i Institut d'Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.
David SantosCIBER de Diabetes y Enfermedades Metabólicas Asociadas, CIBERDEM, 28029 Madrid, Spain.
Victor PallarèsInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau i Institut d'Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0002-9851-0345
Joan Carles Escolà-GilInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau i Institut d'Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0001-9021-2485
Tania Vázquez Del OlmoServei d'Anatomia Patològica, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08041 Barcelona, Spain.
Enrique LermaServei d'Anatomia Patològica, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08041 Barcelona, Spain.
Mercedes CamachoInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau i Institut d'Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0001-5970-3294
Ricardo P Casaroli-MaranoInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau i Institut d'Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-1812-9323
Annabel F ValledorDepartament de Biologia Cel·lular, Fisiologia i Immunologia. Facultat de Biologia, Universitat de Barcelona i Institut de Biomedicina de la Universitat de Barcelona (IBUB), 08028 Barcelona, Spain.ORCID 0000-0003-4232-2633
Francisco Blanco-VacaDepartament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain.ORCID 0000-0001-7380-5385
Josep JulveInstitut de Recerca de l'Hospital de la Santa Creu i Sant Pau i Institut d'Investigació Biomèdica de l'Hospital de la Santa Creu i Sant Pau (IIB-Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0002-6531-2246
Hospital de Sant Pau · ESUniversitat Autònoma de Barcelona · ESInstitut de Biomedicina de la Universitat de BarcelonaCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ES

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca FI-DGR2014CONICYT (Comisión Nacional de Investigación Científica y Tecnología) fellowship PFCHA/DOCTORADO BECAS CHILE/2016-72170639Fundació la Marató de TV3 201602.31Fundació la Marató de TV3 201605-31Instituto de Salud Carlos III CPII18/00004Instituto de Salud Carlos III PI17/00232Instituto de Salud Carlos III PI18/00164Ministerio de Economía, Industria y Competitividad, Gobierno de España RED2018-102799-TMinisterio de Economía, Industria y Competitividad, Gobierno de España SAF2017-89510-RThe National Program Postgraduate Scholarships "DON CARLOS ANTONIO LOPEZ" (BECAL) BCAL04-451 - 3824321
6 · The paper itself

Abstract

The potential of nicotinamide (NAM) to prevent atherosclerosis has not yet been examined. This study investigated the effect of NAM supplementation on the development of atherosclerosis in a mouse model of the disease. The development of aortic atherosclerosis was significantly reduced (NAM low dose: 45%; NAM high dose: 55%) in NAM-treated, apolipoprotein (Apo)E-deficient mice challenged with a Western diet for 4 weeks. NAM administration significantly increased (1.8-fold) the plasma concentration of proatherogenic ApoB-containing lipoproteins in NAM high-dose (HD)-treated mice compared with untreated mice. However, isolated ApoB-containing lipoproteins from NAM HD mice were less prone to oxidation than those of untreated mice. This result was consistent with the decreased (1.5-fold) concentration of oxidized low-density lipoproteins in this group. Immunohistochemical staining of aortas from NAM-treated mice showed significantly increased levels of IL-10 (NAM low-dose (LD): 1.3-fold; NAM HD: 1.2-fold), concomitant with a significant decrease in the relative expression of TNFα (NAM LD: -44%; NAM HD: -57%). An improved anti-inflammatory pattern was reproduced in macrophages cultured in the presence of NAM. Thus, dietary NAM supplementation in ApoE-deficient mice prevented the development of atherosclerosis and improved protection against ApoB-containing lipoprotein oxidation and aortic inflammation.

Indexed as

ATP-binding cassette (ABC) transporterscardiovascular diseasecytokinemacrophageniacinamidevitamin B3

Identifiers

PMID33233455
PMCPMC7700561
OpenAlexW3108050592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.